肝脏局灶性结节性增生的诊治进展

doi:10.3969/j.issn.1009-976X.2022.06.014

摘要/Abstract

摘要： 近年来,肝脏局灶性结节性增生（FNH）的发病率逐渐增高,已成为除肝血管瘤外第二常见的肝脏良性病变,其病程缓慢,出血、破裂等并发症少见,几乎无恶变可能。典型性FNH的影像学有中央瘢痕等特征表现,非典型性FNH的影像学表现各有不同,需结合病史、实验室检查及综合多种影像学检查技术加以诊断及鉴别。FNH的手术适应证要严格掌握。笔者结合国内外相关文献,对FNH的诊治进展进行综述。

关键词: 肝脏局灶性结节增生, 病因, 临床表现, 诊断, 治疗

Abstract: In recent years, the incidence of focal nodular hyperplasia （FNH） in the liver has gradually increased, and it has become the second most common benign liver disease after hepatic hemangioma. Its course is slow, and complications such as bleeding and rupture are rare, almost no possibility of malignant transformation. The imaging features of typical FNH include central scars and other characteristics. The imaging manifestations of atypical FNH are different and should be diagnosed and differentiated by combining medical history, laboratory examinations, and comprehensive imaging techniques. The surgical indications for FNH should be strictly controlled. The author reviewed the progress of diagnosis and treatment of FNH based on relevant domestic and foreign literature.

Key words: hepatic focal nodular hyperplasia, cause of disease, clinical manifestation, diagnosis, treatment

中图分类号:

R657.3

李天伟, 杨宗锐, 邰升. 肝脏局灶性结节性增生的诊治进展[J]. 岭南现代临床外科, 2022, 22(06): 595-599.

LI Tian-wei, YANG Zong-rui, TAI Sheng. Progress in diagnosis and treatment of focal nodular hyperplasia of the liver[J]. Lingnan Modern Clinics In Surgery, 2022, 22(06): 595-599.

参考文献

[1] Vidili G, Piscaglia F, et al.Focal nodular hyperplasia: new findings at Doppler ultrasonography[J]. Eur Rev Med Pharmacol Sci, 2020, 24(23): 12288-12295.
[2] Hamad S, Willyard CE, Mukherjee S.Focal Nodular Hyperplasia [M/OL]. Treasure Island (FL): StatPearls Publishing; 2022. [2022-09-26] https://www.ncbi.nlm.nih.gov/books/NBK532244/
[3] Ashhab AA, Abu-Sulb A, Yang JD, et al.Estrogen-Driven Growth of Focal Nodular Hyperplasia: Truth or Myth?[J]. ACG Case Rep J, 2021, 8(1): e00531.
[4] Kamanda MI, Mathenge MI.Simultaneous occurrence of five prothrombotic induced vaso-occlusive phenomena and focal nodular hyperplasia due to prolonged use of combined oral contraceptive pills[J]. BJR Case Rep, 2017, 4(2): 20170070.
[5] LeGout JD, Bolan CW, Bowman AW, et al. Focal Nodular Hyperplasia and Focal Nodular Hyperplasia-like Lesions[J]. Radiographics, 2022, 42(4): 1043-1061.
[6] Fukahori S, Kawano T, Obase Y, et al.Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use[J]. Am J Case Rep, 2019, 20: 1124-1127.
[7] Chandrasegaram MD, Shah A, Chen JW, et al.Oestrogen hormone receptors in focal nodular hyperplasia[J]. HPB (Oxford), 2015, 17(6): 502-507.
[8] Nolan PE, Catania R, Vendrami CL, et al.Large regenerative nodules and focal nodular hyperplasia-like lesions: definition, pathogenesis, and imaging findings[J]. Radiol Clin North Am, 2022, 60(5): 795-808.
[9] Denk H, Pabst D, Abuja PM, et al.Senescence markers in focal nodular hyperplasia of the liver: pathogenic considerations on the basis of immunohistochemical results[J]. Mod Pathol, 2022, 35(1): 87-95.
[10] Ercan C, Coto-Llerena M, Gallon J, et al.Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case report[J]. Commun Med (Lond), 2022, 2: 11.
[11] Lendvai G, Szekerczés T, Gyöngyösi B, et al.MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular Carcinoma[J]. Pathol Oncol Res, 2019, 25(3): 1103-1109.
[12] Erickson LA, Torbenson MS.Hepatic Focal Nodular Hyperplasia[J]. Mayo Clin Proc, 2020, 95(7): 1557-1558.
[13] Finley AC, Hosey JR, Noone TC, et al.Multiple focal nodular hyperplasia syndrome: diagnosis with dynamic, gadolinium-enhanced MRI[J]. Magn Reson Imaging, 2005, 23(3): 511-513.
[14] Campos Amico E, de Souza IK, Grigório Trigueiro JR, et al. Should focal nodular hyperplasia still be operated upon? Analysis of a case series[J]. Dig Dis, 2019, 37(4): 309-314.
[15] Yasunaka T, Takeuchi Y, Takaki A, et al.A case of focal nodular hyperplasia with hepatic failure treated with liver transplantation[J]. Clin J Gastroenterol, 2022, 15(1): 171-176.
[16] Ben Ismail I, Zenaidi H, Jouini R, et al.Pedunculated hepatic focal nodular hyperplasia: A case report and review of the literature[J]. Clin Case Rep, 2021, 9: e04202
[17] European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the management of benign liver tumours[J]. J Hepatol, 2016, 65(2): 386-398.
[18] Xu R, Wang J, Huang X, et al.Clinical value of spectral CT imaging combined with AFP in identifying liver cancer and hepatic focal nodular hyperplasia[J]. J BUON, 2019, 24(4): 1429-1434.
[19] Hamada K, Saitoh S, Nishino N, et al.An elderly man with progressive focal nodular hyperplasia[J]. Clin J Gastroenterol, 2020, 13(3): 413-420.
[20] Negrão de Figueiredo G, Mueller-Peltzer K, Schwarze V, et al. Long-term study analysis of contrast-enhanced ultrasound in the diagnosis of focal nodular hyperplasia[J]. Clin Hemorheol Microcirc, 2020, 74(4): 441-452.
[21] Jia P, Liu R, Liu Y, et al.Comparison of the Value of Color Doppler Ultrasound and Multislice Spiral CT in the Differential Diagnosis of Benign and Malignant Nodules in the Liver[J].Contrast Media Mol Imaging, 2022, 2022: 5251966.
[22] 严高武, 王金良, 张川等. 肝脏局灶性结节增生的影像学表现及诊治进展[J]. 中华临床医师杂志 (电子版), 2015, 9(5): 829-832.
[23] Dreizin D, Infante J, Tirada N, et al.Focal nodular hyperplasia within accessory liver: imaging findings at computed tomography and magnetic resonance imaging[J]. J Comput Assist Tomogr, 2014, 38(3): 424-426.
[24] Taibbi A, Brancatelli G, Matranga D, et al.Focal nodular hyperplasia: a weight-based, intraindividual comparison of gadobenate dimeglumine and gadoxetate disodium-enhanced MRI[J]. Diagn Interv Radiol, 2019, 25(2): 95-101.
[25] Bioulac-Sage P, Cubel G, Taouji S, et al.Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes[J]. Am J Surg Pathol, 2012,36(11):1691-9.
[26] Cheng N, Ren Y, Zhou J, et al. Deep Learning-Based Classification of Hepatocellular Nodular Lesions on Whole-Slide Histopathologic Images[J]. Gastroenterology,2022 Jun;162(7):1948-1961. e7.
[27] Zhu M, Li H, Wang C, et al.Focal nodular hyperplasia mimicking hepatocellular adenoma and carcinoma in two cases[J]. Drug Discov Ther, 2021, 15(2): 112-117.
[28] Oldhafer KJ, Habbel V, Horling K, et al.Benign Liver Tumors[J]. Visc Med, 2020, 36(4): 292-303.
[29] Park HJ, Byun JH, Kang JH, et al.Value of discrepancy of the central scar-like structure between dynamic CT and gadoxetate disodium-enhanced MRI in differentiation of focal nodular hyperplasia and hepatocellular adenoma[J]. Eur J Radiol, 2021, 139: 109730.
[30] Perrakis A, Vassos N, Grützmann R, et al.What is Changing in Indications and Treatment of Focal Nodular Hyperplasia of the Liver. Is There Any Place for Surgery?[J]. Ann Hepatol, 2017, 16(3): 333-341.
[31] Jung JM, Hwang S, Kim KH, et al.Surgical indications for focal nodular hyperplasia of the liver: Single-center experience of 48 adult cases[J]. Ann Hepatobiliary Pancreat Surg, 2019, 23(1): 8-12.
[32] Pompili M, Ardito F, Brunetti E, et al.Benign liver lesions 2022: Guideline for clinical practice of Associazione Italiana Studio del Fegato (AISF), Società Italiana di Radiologia Medica e Interventistica (SIRM), Società Italiana di Chirurgia (SIC), Società Italiana di Ultrasonologia in Medicina e Biologia (SIUMB), Associazione Italiana di Chirurgia Epatobilio-Pancreatica (AICEP), Società Italiana Trapianti d′Organo (SITO), Società Italiana di Anatomia Patologica e Citologia Diagnostica (SIAPEC-IAP) - Part II - Solid lesions[J]. Dig Liver Dis, 2022, 54(12):1614-1622.
[33] Marrero JA, Ahn J, Rajender Reddy K, et al. ACG clinical guideline: the diagnosis and management of focal liver lesions[J]. Am J Gastroenterol, 2014, 109(9):1328-47; quiz 1348.
[34] Virgilio E, Cavallini M.Managing Focal Nodular Hyperplasia of the Liver: Surgery or Minimally-invasive Approaches? A Review of the Preferable Treatment Options[J]. Anticancer Res, 2018, 38(1): 33-36.
[35] Wilhelm L, Albrecht L, Kirsch M, Heidecke CD.Preoperative application of selective angiographic embolization in the treatment of focal nodular hyperplasia[J]. Surg Laparosc Endosc Percutan Tech, 2006, 16(3): 177-181.
[36] Perrakis A, Demir R, Müller V, et al.Management of the focal nodular hyperplasia of the liver: evaluation of the surgical treatment comparing with observation only[J]. Am J Surg, 2012, 204(5): 689-696.
[37] Reinhart MB, Huntington CR, Blair LJ, et al.Indocyanine Green: Historical Context, Current Applications, and Future Considerations[J]. Surg Innov, 2016, 23(2): 166-175.
[38] Li CG, Zhou ZP, Tan XL, et al.Robotic resection of liver focal nodal hyperplasia guided by indocyanine green fluorescence imaging: A preliminary analysis of 23 cases[J]. World J Gastrointest Oncol, 2020, 12(12): 1407-1415.